You are here: Industry Insights > cell and gene therapy

News List

Hitachi Chemical’s Regenerative Medicine Business Rebrands contractpharma
September 24, 2020
Changes its name to Minaris Regenerative Medicine.
BioLife Solutions Acquires SciSafe contractpharma
September 22, 2020
Enables BioLife to offer more value to its cell and gene therapy customers.
Thermo Fisher Launches Offering to Facilitate cGMP-Compatible Cell, Gene Therapy Manufacturing americanpharmaceuticalreview
July 29, 2020
Thermo Fisher Scientific announces the launch of a compliance and services portfolio, compatible with current Good Manufacturing Practice (cGMP) and designed to enable rapid start-up of clinical and commercial cell and gene therapy manufacturing.
UK government invests £100 million into COVID-19 vaccine manufacturing europeanpharmaceuticalreview
July 28, 2020
The UK government has committed £100 million to establish a centre to scale up COVID-19 vaccine and gene therapy manufacturing.
GenScript Expands CDMO Capabilities contractpharma
July 24, 2020
Launches CDMO segment "GenScript ProBio" at inaugural GenScript Cell and Gene Therapy Industry Development & Cooperation Forum in Shanghai.
WuXi Launches CAR-T Cell Therapy Platform contractpharma
May 19, 2020
Will enable biotechnology companies and researchers to accelerate the development, manufacturing and release of cell and gene therapies for patients.
Univercells Launches Bioprocess Technologies Subsidiary contractpharma
May 07, 2020
Will focus on the development and commercialization of intensified, automated biomanufacturing technologies.
NJII Launches BioCentriq Cell & Gene Therapy Mfg. Center contractpharma
May 07, 2020
Process development and clinical manufacturing facility for cell and gene therapies becomes first of its kind located on a U.S. university campus.
Univercells Launches Cell & Gene Therapy CDMO Exothera contractpharma
March 23, 2020
Will partner with innovators to unlock their manufacturing potential by capitalizing on best-in-class manufacturing technologies and bioprocessing expertise.
UK accounts for 12 percent of global cell and gene therapy clinical trials europeanpharmaceuticalreview
January 19, 2020
New research has found that the cell and gene therapy clinical environment in the UK has encouraged commercial sponsorship from around the world.

Previous page 1 2 3 4 5 Next page